ABOUT JIRUI TECH
Multiple sets of modular, multi-functional
Intelligent automatic synthesis platform for radiopharmaceuticals
Hangzhou Jirui Technology Co., Ltd., established in September 2018, is a new star, and its brand value has gradually formed an influence in the field of medical imaging. The company is mainly engaged in the research and development and sales of radiopharmaceutical synthesis systems, and has built a number of modular, multi-functional intelligent radiopharmaceutical automatic synthesis platforms, which can stably complete the high-throughput preparation of radiopharmaceuticals in different synthesis pathways and meet strict clinical-level quality control requirements.
OUR PRODUCTS
Core Products
Design and manufacture of advanced automatic synthesis systems for radioactive drugs, as well as the design, synthesis, and production of PET tracers
INNOVATIVE IDEAS
Core competitiveness
Nuclear drug synthesis
The synthesis of 18F, 11C, 68Ga, and other nuclide tracers has reached the same level as the mainstream foreign tracer synthesis platform;
Efficient reaction: high pressure reactor; water cooling.
Friendly interaction:The operation interface is simple, the degree of automation is high, the modular design, the custom operation is simple, to meet the needs of scientific research.
Security:Adopt negative pressure production and timely recovery of waste gas waste liquid to prevent the flow and overflow of radiation particles.
PARTNER
Partners
The company's core products include the design and manufacture of advanced radiopharmaceutical automated synthesis systems and the design, synthesis and production of PET tracers.
Explore more →